MCP-1 Promoter Polymorphism at −2518 Is Associated with Metastasis of Nasopharyngeal Carcinoma after Treatment
- 1 November 2007
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 13 (21) , 6320-6326
Abstract
Purpose: We herein examined whether the single nucleotide polymorphism (SNP) at −2518 of the MCP-1 gene promoter region influences clinical outcomes among nasopharyngeal carcinoma (NPC) patients. Experimental Design: The study population consisted of 411 NPC patients without metastasis at diagnosis. All patients were treated at the Chang Gung Memorial Hospital from March 1994 to November 2004. The MCP-1 SNP−2518 genotype of each patient was determined by TaqMan genotyping kit. Statistical analyses were conducted to compare disease-specific survival (DSS), progression-free survival (PFS), local recurrence-free survival (LRFS), and distant metastasis-free survival (DMFS) of patients according to genotype. MCP-1 expression in tumor biopsies was examined by immunohistochemistry. Results: Among 411 NPC patients, carriers of AA and AG genotypes were prone to distant metastasis than that of GG genotype (hazard ratio, 2.21; P = 0.017, and hazard ratio, 2.23; P = 0.005, for AA and AG genotype, respectively) after initial radiotherapy. No genotype-specific significant difference was found in DSS, PFS, and LRFS. Furthermore, immunohistochemistry revealed that MCP-1 expression level was higher in NPC tumor cells from GG carriers compared with those from AA and AG carriers. Conclusions:MCP-1 SNP−2518 may be a valuable genetic marker for assessing the risk of developing distant metastasis after the radiotherapy in NPC patients. Carriers of A allele may require more aggressive chemotherapy implicating a potential marker for personalized medicine. We speculate that a regulatory SNP may be associated with the distant metastasis of NPC. Validation studies are warranted.Keywords
All Related Versions
This publication has 37 references indexed in Scilit:
- Epstein-Barr Virus Induces MCP-1 Secretion by Human Monocytes via TLR2Journal of Virology, 2007
- Human herpesvirus 8 acute infection of endothelial cells induces monocyte chemoattractant protein 1–dependent capillary-like structure formation: role of the IKK/NF-κB pathwayBlood, 2006
- Host genetics influence tumour metastasisNature Reviews Cancer, 2006
- Correlations between Serum Monocyte Chemotactic Protein-1 Levels, Clinical Prognostic Factors, and HER-2/neu Vaccine-Related Immunity in Breast Cancer PatientsClinical Cancer Research, 2006
- Epstein-barr virus latent membrane protein 1: Structure and functionsJournal of Biomedical Science, 2003
- Plasma Epstein-Barr Virus DNA and Residual Disease After Radiotherapy for Undifferentiated Nasopharyngeal CarcinomaJNCI: Journal of the National Cancer Institute, 2002
- Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4Nature Genetics, 2002
- Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1Nature, 2000
- A Novel Polymorphism in the MCP-1 Gene Regulatory Region That Influences MCP-1 ExpressionBiochemical and Biophysical Research Communications, 1999
- The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer.Journal of Clinical Investigation, 1995